Conditions: Epilepsy
Keywords: Epilepsy Partial-onset Seizures Lacosamide Monotherapy Vimpat
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 322
Healthy volunteers: no

Brief summary:
This open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset seizures who were previously enrolled in the conversion to monotherapy trial (SP902).

Detailed description:

Arms:
arm 1: Lacosamide tablets for dosing 100 -800 mg/day

Interventions: intervention 1: Lacosamide
Intervention descriptions: intervention 1: 50 mg and 100 mg Lacosamide tablets taken for 50 -400 mg twice daily dosing for up to 2 years

Protocol document: